[Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis]. [electronic resource]
- Medizinische Klinik (Munich, Germany : 1983) Oct 2007
- 852-7 p. digital
Publication Type: Case Reports; English Abstract; Journal Article
0723-5003
10.1007/s00063-007-1104-6 doi
Adrenal Cortex Hormones--therapeutic use Aged Antibodies, Antinuclear--blood Arthritis, Psoriatic--drug therapy Biopsy Cyclophosphamide--therapeutic use Drug Therapy, Combination Etanercept Humans Immunoglobulin G--adverse effects Immunosuppressive Agents--adverse effects Kidney--pathology Kidney Function Tests Lupus Erythematosus, Systemic--chemically induced Lupus Nephritis--chemically induced Male Receptors, Tumor Necrosis Factor--therapeutic use Tumor Necrosis Factor-alpha--antagonists & inhibitors